Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Redhill Biophrma ADR (RDHL)

Redhill Biophrma ADR (RDHL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 339,147
  • Shares Outstanding, K 46,395
  • Annual Sales, $ 64,360 K
  • Annual Income, $ 76,170 K
  • 60-Month Beta 1.46
  • Price/Sales 4.84
  • Price/Cash Flow N/A
  • Price/Book 22.45
Trade RDHL with:

Options Overview

Details
  • Implied Volatility 109.03%
  • Historical Volatility 56.45%
  • IV Percentile 10%
  • IV Rank 19.70%
  • IV High 186.30% on 01/27/21
  • IV Low 90.07% on 03/18/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 213
  • Volume Avg (30-Day) 536
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 10,420
  • Open Int (30-Day) 9,964

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.42
  • Number of Estimates 1
  • High Estimate -0.42
  • Low Estimate -0.42
  • Prior Year -0.49
  • Growth Rate Est. (year over year) +14.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.60 +6.06%
on 04/09/21
8.31 -15.76%
on 03/16/21
-0.90 (-11.39%)
since 03/12/21
3-Month
6.60 +6.06%
on 04/09/21
11.52 -39.24%
on 02/22/21
-0.52 (-6.91%)
since 01/12/21
52-Week
5.93 +18.04%
on 04/17/20
11.52 -39.24%
on 02/22/21
+0.95 (+15.70%)
since 04/09/20

Most Recent Stories

More News
RedHill Biopharma's Phase 2/3 COVID-19 Study of Opaganib Passes Fourth DSMB Review with Unanimous Recommendation to Continue

and , /PRNewswire/ -- (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the global Phase 2/3 study with orally-administered opaganib (Yeliva, ABC294640)[1]...

RDHL : 7.00 (-4.24%)
RedHill Biopharma Announces Settlement of Movantik® Patent Litigation with MSN Pharmaceuticals

and , /PRNewswire/ -- (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that RedHill Biopharma Inc., AztraZeneca AB and AstraZenca Pharmaceuticals LP...

RDHL : 7.00 (-4.24%)
RedHill Biopharma Announces Compassionate Use Treatment with Opaganib of first COVID-19 Patients in Switzerland

and , /PRNewswire/ -- (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has acted on a request to provide opaganib treatment on an outpatient...

RDHL : 7.00 (-4.24%)
Proactive news headlines including Silver Range Resources, Vuzix Corp, Endeavour Mining and Delta 9 Cannabis

- Altiplano Metals closes C$3.1 million non-brokered private placement click here

SNG.VN : 0.175 (-7.89%)
VST.CN : 0.870 (-3.33%)
VSQTF : 0.6885 (-4.26%)
RDHL : 7.00 (-4.24%)
GEM : 39.48 (-0.75%)
MEEC : 1.1400 (-1.72%)
RCRT : 3.0700 (-5.54%)
VR.CN : 0.095 (unch)
VRCFF : 0.0765 (+5.96%)
ALPP : 3.6900 (-2.38%)
ORGS : 5.22 (-2.06%)
TCF.CN : 0.375 (+1.35%)
TCFF : 0.3025 (+2.47%)
AREC : 3.60 (-3.23%)
BRC : 55.35 (+0.64%)
CBDHF : 1.5585 (-6.11%)
SFET : 1.6500 (unch)
NEXNF : 1.3651 (-7.53%)
MRBL.CN : 0.265 (+12.77%)
MRBLF : 0.2093 (+4.23%)
SLRRF : 0.1547 (+1.05%)
FF : 13.95 (+0.94%)
FFMGF : 0.2852 (-1.66%)
ARU : 25.20 (-0.32%)
VUZI : 26.23 (-10.39%)
EDV : 126.94 (unch)
EDVMF : 21.6510 (-2.08%)
PYR.TO : 7.74 (-3.97%)
PYR : 6.20 (-4.47%)
NC.CN : 0.880 (+6.02%)
NTTCF : 0.7080 (+7.06%)
VLNCF : 2.0025 (-4.31%)
XPHY.CN : 2.600 (-0.38%)
XPHYF : 2.0800 (-2.12%)
CANN.CN : 0.130 (unch)
HERTF : 0.1000 (-7.58%)
MTRX : 13.41 (+0.07%)
RACMF : 1.3300 (-4.32%)
DN.TO : 0.59 (unch)
DLTNF : 0.4750 (+1.02%)
PRSRF : 0.3184 (+1.27%)
RedHill Biopharma Provides Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights

and , /PRNewswire/ --

RDHL : 7.00 (-4.24%)
RedHill Biopharma to Host Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights Webcast on March 18, 2021

and , /PRNewswire/ --  (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it will report its fourth quarter and full year 2020 financial results...

REDIF : 0.6700 (unch)
RDHL : 7.00 (-4.24%)
RedHill to Present at Upcoming Conferences in March

and , /PRNewswire/ -- (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it will present at the following upcoming virtual conferences in March:

RDHL : 7.00 (-4.24%)
RedHill Biopharma Announces Closing of $35 Million Bought Deal Offering of American Depositary Shares

and , /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the closing of its previously announced underwritten public offering...

RDHL : 7.00 (-4.24%)
ObvioHealth and RedHill Biopharma Launch First in Kind Remote COVID-19 Therapy Trial Incorporating Highest Level of At-home Patient Monitoring to Date

, /PRNewswire/ -- , a global virtual research organization or VRO, today announced the launch of a hybrid clinical trial for the treatment of COVID-19, using an innovative study design with digital data...

RDHL : 7.00 (-4.24%)
RedHill Biopharma Increases Previously Announced Bought Deal to $35 Million of American Depositary Shares

and , /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that due to demand, the underwriter has agreed to increase...

REDIF : 0.6700 (unch)
RDHL : 7.00 (-4.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

RedHill Biopharma Ltd. is a specialty biopharmaceutical company, focused on gastrointestinal and infectious diseases. It operates through the Commercial Operations segment and the Research & Development segment. The Commercial Operations segment is based in Raleigh, NC, and covers all areas relating...

See More

Key Turning Points

3rd Resistance Point 7.68
2nd Resistance Point 7.53
1st Resistance Point 7.26
Last Price 7.00
1st Support Level 6.84
2nd Support Level 6.69
3rd Support Level 6.42

See More

52-Week High 11.52
Fibonacci 61.8% 9.38
Fibonacci 50% 8.73
Fibonacci 38.2% 8.07
Last Price 7.00
52-Week Low 5.93

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar